TMEM106A Antibody is affinity chromatography purified via peptide column.
Immunogen
TMEM106A antibody was raised against a 14 amino acid synthetic peptide near the amino terminus of human TMEM106A. The immunogen is located within the first 50 amino acids of TMEM106A.
TMEM106A
Reactivity: Human
ELISA, IF/ICC
Host: Rabbit
Polyclonal
unconjugated
Application Notes
TMEM106A antibody can be used for detection of TMEM106A by Western blot at 1 μ,g/mL. Antibody can also be used for immunohistochemistry starting at 5 μ,g/mL. For immunofluorescence start at 5 μ,g/mL.
Antibody validated: Western Blot in mouse samples, Immunohistochemistry in mouse samples and Immunofluorescence in mouse samples. All other applications and species not yet tested.
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
TMEM106A Antibody is supplied in PBS containing 0.02 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C,4 °C
Storage Comment
TMEM106A antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
TMEM106A Antibody: Transmembrane protein 106A (TMEM106A) is a single-pass transmembrane protein that is closely related to TMEM106B, a protein that is thought to be a novel risk factor for frontotemporal lobar degeneration (FTLD), a group of clinically, pathologically and genetically heterogeneous disorders associated with atrophy in the frontal lobe and temporal lobe of the brain. The actual roles of TMEM106A and TMEM106B are still undetermined, however, as TMEM106B is involved in FTLD, it is possible that TMEM106A may also be a risk factor for FTLD.